Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance.

Raschi, Emanuel; Fusaroli, Michele; Diemberger, Igor; Poluzzi, Elisabetta

Raschi, Emanuel; Fusaroli, Michele; Diemberger, Igor; Poluzzi, Elisabetta.

Raschi E; Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Via Irnerio 48, 40126, Bologna, Italy. emanuel.raschi@unibo.it.
Fusaroli M; Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Via Irnerio 48, 40126, Bologna, Italy.
Diemberger I; Cardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Poluzzi E; Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Via Irnerio 48, 40126, Bologna, Italy.

Drug Saf ; 43(11): 1191-1194, 2020 11.

Article in English | MEDLINE | ID: covidwho-1077703

Subject(s)

Anticoagulants/adverse effects; Anticoagulants/therapeutic use; Lung Diseases, Interstitial/chemically induced; Pharmacovigilance; Administration, Oral; Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants/administration & dosage; Female; Global Health; Humans; Lung Diseases, Interstitial/mortality; Lung Diseases, Interstitial/pathology; Male; United States; United States Food and Drug Administration

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lung Diseases, Interstitial / Pharmacovigilance / Anticoagulants Type of study: Prognostic study Limits: Aged / Female / Humans / Male Country/Region as subject: North America Language: English Journal: Drug Saf Journal subject: Drug Therapy / Toxicology Year: 2020 Document Type: Article Affiliation country: S40264-020-00990-9

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google